Using RNA-seq for diagnosis of acute lymphoblastic leukemia
Short interview with Key Opinion Leader Thoas Fioretos, Professor in Clinical Genetics, Lund University, Sweden about the benefits using RNA seq for diagnosis of Acute lymphoblastic leukemia (ALL).
The great majority of ALLs are characterized by gene fusions or display a distinct gene expression signature that can be used for classification purposes. Here are some of the discussed benefits:
Improved diagnostics workflow using RNA sequencing in ALL
Gene expression subtype classification of ALL samples using RNA sequencing
Importance of Gene fusion analysis in diagnostics ALL.